Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study

被引：0
|
作者：
Westhovens, Rene [1 ]
van der Aa, Annegret [2 ]
Jamoul, Corinne [2 ]
Tasset, Chantal [2 ]
Harrison, Pille [2 ]
机构：
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
[2] Galapagos NV, Mechelen, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
GLPG0634/GS-6034; INHIBITOR;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
534
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EFFECT OF BASELINE SERUM CRP LEVELS ON CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH FILGOTINIB: POST-HOC ANALYSIS FROM TWO PHASE 2B STUDIES
    Westhovens, R.
    Kavanaugh, A.
    Jamoul, C.
    Tasset, C.
    Harrison, P.
    Van der Aa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 148 - 148
  • [2] No Effect of Baseline Serum CRP Levels on Clinical Efficacy Parameters in Rheumatoid Arthritis Patients Treated with Filgotinib: Post Hoc Analysis from Two Phase 2B Studies
    Kavanaugh, Arthur
    Van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    Westhovens, Rene
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Association between Clinical Response and Normalization of Patient-Reported Outcome Measures in Rheumatoid Arthritis: Post-Hoc Analysis from Two Phase 2b Filgotinib Studies
    Genovese, Mark C.
    Van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    Westhovens, Rene
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, P.
    Downie, B.
    Liu, J.
    Hawtin, R.
    Curtis, J. R.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 502 - 502
  • [5] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, Paul
    Downie, Bryan
    Liu, Jinfeng
    Hawtin, Rachael E.
    Curtis, Jeffrey R.
    Burmester, Gerd R.
    RHEUMATOLOGY, 2022, 61
  • [6] Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study
    Watanabe, Kenji
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Fujitani, Yasushi
    Faes, Margaux
    Oortwijn, Alessandra
    Lindsay, James O.
    Rogler, Gerhard
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 801 - 811
  • [7] Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Haaland, Derek
    Hall, Stephen
    Inanc, Nevsun
    Li, Zhanguo
    Xavier, Ricardo M. M.
    Cara, Carlos
    Tilt, Nicola
    Taylor, Peter C. C.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (07) : 1248 - 1259
  • [8] HEPATITIS B VIRUS REACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BARICITINIB: POST-HOC ANALYSIS FROM CLINICAL TRIALS
    Harigai, M.
    Winthrop, K.
    Takeuchi, T.
    Hsieh, T. -Y.
    Chen, Y. -M.
    Smolen, J. S.
    Burmester, G. R.
    Walls, C.
    Wu, W. -S.
    Dickson, C.
    Liao, R.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 584 - 585
  • [9] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis
    Aletaha, Daniel
    Westhovens, Rene
    Gaujoux-Viala, Cecile
    Adami, Giovanni
    Matsumoto, Alan
    Bird, Paul
    Messina, Osvaldo Daniel
    Buch, Maya
    Bartok, Beatrix
    Yin, Zhaoyu
    Guo, Ying
    Hendrikx, Thijs
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
    Hibi, Toshifumi
    Motoya, Satoshi
    Hisamatsu, Tadakazu
    Hirai, Fumihito
    Watanabe, Kenji
    Matsuoka, Katsuyoshi
    Saruta, Masayuki
    Kobayashi, Taku
    Feagan, Brian G.
    Tasset, Chantal
    Besuyen, Robin
    Yun, Chohee
    Crans, Gerald
    Zhang, Jie
    Kondo, Akira
    Watanabe, Mamoru
    INTESTINAL RESEARCH, 2022, : 110 - 125
12345